NexMR AG
|
Year Established:
2022 |
|
|
Website:
nexmr.com |
|
|
Headquarters:
Schlieren, Zurich, CH |
|
|
Company Type:
New Startup (0-1M TTM Revenue) |
NexMR is an ETH Zürich spin-off company specializing in cutting-edge NMR technologies for fragment-based drug design.
Our hyperpolarized NMR platform is 50x faster and uses up to 20x less protein concentration. We have a library with hyperpolarizable molecules containing approximately 500 fragments (in stock) and up to 5,000 fragments (on demand).
Our service platform provides:
Screening: deliverable is a hit list
Affinity determination: deliverable is an affinity (dissociation constant, Kd)
| Site | Badges | |
|---|---|---|
| NexMR AG - HQ Wiesenstrasse 10A Schlieren, Zurich, 8952 Switzerland | ||
| NexMR AG - Lab Wiesenstrasse 10A Schlieren, Zurich, 8952 Switzerland | ||
Get started
If your organization has a Scientist.com marketplace, you can log in here to order products and services directly. If you're interested in ordering custom research services from suppliers in the Scientist.com network, book a meeting with our team here. To order products instantly, request access below.